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Purpose: To evaluate differences in prescription medication adherence rates,
as well as influencing factors, in rural and urban adults.
Methods: This is a retrospective analysis of the 2015 National Consumer Survey on the Medication Experience and Pharmacists’ Role. A total of 26,173
participants completed the survey and provided usable data. Participants using between 1 and 30 prescription medications and living more than 0 miles
and up to 200 miles from their nearest pharmacy were selected for the study,
resulting in a total of 15,933 participants. Data from the 2010 US Census and
Rural Health Research Center were used to determine the population density
of each participant’s ZIP code. Participant adherence to reported chronic medications was measured based on the 8-item Morisky Medication Adherence
Scale (MMAS-8).
Findings: Overall adherence rates did not differ significantly between rural
and urban adults with average adherence based on MMAS-8 scores of 5.58
and 5.64, respectively (P = .253). Age, income, education, male sex, and white
race/ethnicity were associated with higher adherence rates. While the overall
adherence rates between urban and rural adults were not significantly different, the factors that influenced adherence varied between age-specific population density groupings.
Conclusion: These analyses suggest that there is no significant difference in
adherence between rural and urban populations; however, the factors contributing to medication adherence may vary based on age and population density. Future adherence intervention methods should be designed with consideration for these individualized factors.
Key words access to care, health care access, medication adherence, medication use, pharmacy.

Medication nonadherence is considered one of the greatest modifiable health risks to exist in the United States.
Nearly half of all Americans who are prescribed a prescription medication are nonadherent to it.1 The presence
of nonadherence to prescription medications causes poor
health-related outcomes. Nonadherence has been shown
to increase the likelihood of disease progression, lead to

higher utilization of health care services, increase the cost
of care, and cause higher mortality rates.2-9
The cause of nonadherence is complex and there
are many factors that have been linked to increasing
rates of nonadherence. These include factors related
to the cost of the medications, socioeconomic status,
and convenience.10-15 With increasing rates of poverty
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among those living in rural areas, overall lower median
household income for rural dwellers compared to urban dwellers, reduced rates of insurance coverage for rural dwellers, and increased distance to health care services among individuals living in rural communities, one
would assume the risk of nonadherence is increased
among those living in rural communities.16-19
Nearly 50 million individuals are reported to live in rural settings across the United States.19 Research has continued to show that health-related outcomes are often
worse across chronic diseases for individuals living in rural settings.17,20 The cause of these poor outcomes is often the center of debate; however, some studies have
suggested that access to health care services and medications may contribute.17,21,22 There has been limited research to assess differences in medication adherence in
rural and urban communities.23 As most chronic conditions are currently treated through the use of chronic prescription medications, it is important to evaluate if differences in the use of prescription medications exist between
rural and urban populations.
The objective of this study is to compare adherence
rates between rural and urban populations. Additionally, the study evaluates differences between known
factors that impact adherence among rural and urban
populations.

Methods
Database
This study was a retrospective analysis of the 2015 National Consumer Survey on the Medication Experience
and Pharmacists’ Role. The 2015 National Consumer Survey was conducted using Qualtrics Panels (Qualtrics LLC,
Provo, Utah) to provide participant panels and enroll participants based on census statistics for geographic location, age, and gender. Qualtrics Panels is an online sample
of study participants maintained by the online survey system, Qualtrics. Participants were recruited online actively
by Qualtrics from this sample and results were provided
to researchers. All communications to potential participants were delivered electronically. Participation stratification was included to ensure a minimum of 500 respondents from each of the 50 states and the District of
Columbia. A total of 26,173 participants completed the
study and provided useable data.

Study Population
The study sample included US residents aged 18 years
and older at the time of completion. The data were collected in 2015. The sample included all participants from

the original data set, but it was limited to those using
prescription medications. Data were restricted to include
those using between 1 and 30 prescription medications.
Additionally, participants with incomplete responses and
those reporting living over 200 miles from the nearest
pharmacy or living 0 miles from the nearest pharmacy
were excluded from the sample.

Variables
Adherence to reported chronic medications was measured based on the 8-item Morisky Medication Adherence Scale (MMAS-8). The scale has been proven
to be a reliable and valid measure of patient-reported
adherence.24-26 The scoring of responses range from 0
(worse possible adherence score) to 8 (best possible adherence score). The scores for participant MMAS-8 were
reported both as raw scores ranging from 0 to 8 and
grouped by level of adherence, with those scoring less
than 6 being defined as low adherers, those scoring 6 to
less than 8 defined as medium adherers, and those scoring 8 as high adherers, as recommended.24
Participant-reported ZIP codes were compared to ruralurban commuting area (RUCA) scores compiled by the
Rural Health Research Center to assign each participant’s
population density as rural, suburban, or urban. RUCA
scores classify US Census tracts using measures of population density, urbanization, and daily commuting. The
latest version of RUCA scoring, based on 2010 Census
data, provides a cross-walk between ZIP codes and RUCA
score. Participants residing in a ZIP code with a RUCA
score of greater than 6 were defined as rural, those with
a RUCA score of between 2 and 6 were defined as suburban, and those with a RUCA score of 1 were defined as
urban.
An abbreviated version of the Beliefs about Medicines
Questionnaire (BMQ) was used to gain participants’ perception regarding the necessity of and concerns about
medications.27 Individual question responses were used
to establish participant harm, overuse, life-saving, and
burden belief. Composite scoring for the BMQ was not
used as the survey did not include the full BMQ questionnaire, which restricted scoring to responses to individual items. Participants rated agreement with included statements based on a 7-point Likert scale. Based
upon the Concerns-Necessity Framework, necessity beliefs have previously been shown to be positively related
to medication adherence, while concerns, overuse beliefs, and harm beliefs have been shown to be negatively
related.28 Additionally, respondents were also asked to
rate their level of agreement using the same Likert scale
to the statement, “Purchasing medications causes me financial hardship.” This served as the marker for financial
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hardship, with higher numerical values being associated
with greater levels of agreement that purchasing medications cause financial hardship. Participants were also
asked to rate their overall health on a 4-point scale, ranging from excellent to poor.

Analysis
Participant demographics and characteristics, medication
adherence, and population density of ZIP code were reported using descriptive statistics. Multivariate regression
analyses were used to assess associations between medication adherence (the dependent variable) and education level, household income, medications causing financial hardship, age, self-rated health score, distance
to the nearest pharmacy, use of mail order pharmacies,
use of the drive-through at their pharmacy, medication
burden belief, medication life-saving belief, medication
overuse belief, total number of prescription medications
taken daily, and medication harm belief (independent
variables). All independent variables were added to the
models at the same time. Education level, household income, use of mail order pharmacies, and use of a drivethrough at the pharmacy were treated as categorical variables, with lowest level of education and lowest income
level serving as the reference level. As it was hypothesized that the importance of these factors differed between rural, suburban, and urban participants, separate
models were constructed for each cohort. Additionally,
these cohorts were further deconstructed by age groups
because of the significant difference in age groupings between cohorts, and regression models were constructed
for each subset.

Software
All participants’ records were stored in a relational
database using the open-source database software
MySQL (v. 5.7.11, Oracle, Redwood Shores, California).
All analytics were performed using the open-source statistical computing software R (v 3.2.3, R Foundation,
Vienna, Austria).

Results
Of the 26,173 participants, 16,677 reported taking between 1 and 30 prescription medications. Of those taking
prescription medications, a total of 15,933 participants
met the additional inclusion criteria. Based on the 2010
RUCA designations, a total of 1,735 participants were rural dwellers, 5,302 were suburban dwellers, and 8,896 urban dwellers.

Medication Adherence in Rural, Urban, and Suburban

The demographic makeup of the 3 levels of population density varied significantly, with individuals under
the age of 41 making up over 44% of the population for
urban centers while this same age group accounted for
only 35% of the population in rural areas. Conversely,
individuals over the age of 54 accounted for a larger proportion of rural participants, with 44% of them living in
rural areas and 37% in urban areas. The difference in the
age distribution results in rural areas having an average
age of 49.1 years and urban areas having an average age
of 46.3 years (P < .005; Table 1).
Income distribution was similarly unevenly distributed
between the 3 subgroups. The percentage of individuals
with a household income of less than $40,000 per year
was greatest among rural participants, compared to suburban and urban areas (54.9%, 46.2%, and 39.7%, respectively). Differences also existed by educational status,
sex, and ethnicity. Table 1 provides further demographic
information about the participants contained within each
group. The overall mean adherence score based on the
MMAS-8 was 5.6 (SD = 2.0) for all participants. The
mean adherence score was compared for rural, suburban,
and urban participants, as was the proportion of participants meeting certain adherence criteria. There was no
significant difference between each of the groups based
on mean adherence scores (Table 2). Rurality groups had
roughly equivalent proportions of individuals classified
as low adherence (MMAS-8 < 6; rural 49.5%, suburban
50.3%, and urban 50.7%), medium adherence (MMAS8 ࣙ 6 and < 8; rural 27.5%, suburban 28.2%, and urban
28.3%) and high adherence (MMAS-8 = 8; rural 23.1%,
suburban 21.6%, and urban 21.0%; Table 2).
Based on subset analyses of each of the designations
according to population density, similar adherence scores
were also shown between rural, suburban, and urban
participants when categorized by other demographic factors. For instance, there were no statistically significant
differences in medication adherence scores between rural, urban, and suburban participants when comparing
the same age groups, income groups, education level, sex,
and ethnicity (Table 3).
A multivariable linear regression was constructed for
all participants, as well as separately for rural participants
and urban participants (Table 4). The results of the overall and separated rural versus urban regression models
showed similarities. However, some factors included in
the model had significance only in urban participants and
not rural participants, including distance to pharmacy
(B = −0.01, P < .001), use of mail order pharmacies (B =
−0.14, P = .002), and perceptions of medication-related
factors.
To better understand potential differences among various age groups of rural and urban dwellers, a series of
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Table 1 Demographics of Participants, Separated Based on Rural, Suburban, or Urban Dwelling
Rural

Suburban

Urban

Significancea

1,735 (10.9%)
49.1
3.7

5,302 (33.28%)
47.9
3.6

8,896 (55.83%)
46.3
3.3

<.005
<.005

245 (14.1%)
357 (20.6%)
376 (21.7%)
406 (23.4%)
351 (20.2%)

872 (16.5%)
1,131 (21.3%)
1,155 (21.8%)
1,118 (21.1%)
1,026 (19.4%)

1,832 (20.6%)
2,112 (23.7%)
1,642 (18.5%)
1,590 (17.9%)
1,720 (19.3%)

<.005
<.005
<.005
<.005
.676

953 (54.9%)
658 (37.9%)
124 (7.2%)

2,451 (46.2%)
2,360 (44.5%)
491 (9.3%)

3,528 (39.7%)
4,193 (47.1%)
1,175 (13.2%)

<.005
<.005
<.005

521 (30.0%)
1,052 (60.6%)
162 (9.3%)

1,283 (24.2%)
3,463 (65.3%)
556 (10.5%)

1,673 (18.8%)
5,961 (67.0%)
1,262 (14.2%)

<.005
<.005
<.005

409 (23.6%)
1,326 (76.4%)

1,374 (25.9%)
3,928 (74.1%)

2,585 (29.1%)
6,311 (70.9%)

<.005
<.005

1,594 (91.9%)
141 (8.1%)

4,681 (88.3%)
621 (11.7%)

7,101 (79.8%)
1,795 (20.2%)

<.005
<.005

Variables
Total participants
Mean age
Mean medication count
Age group
18-29
30-41
42-53
54-65
Over 65
Income
Income at or below $40,000
Income between $41,000 and $100,000
Income over $100,000
Education
High school degree or less
Some college to bachelor’s degree
Advanced degree
Sex
Male
Female
Ethnicity
White
Non white

a
Significance reported as P values from chi-square difference test.
P < .05 considered significant.

Table 2 Adherence Rates within Rural, Urban, and Suburban Settings

Average MMAS-8 score (SD)a
Low adherence N (%)b
Medium adherence N (%)b
High adherence N (%)b

Rural (N = 1,735)

Suburban (N = 5,302)

Urban (N = 8,896)

Significance

5.64 (2.04)
858 (49.5%)
477 (27.5%)
400 (23.1%)

5.64 (2.02)
2,664 (50.3%)
1,493 (28.2%)
1,145 (21.6%)

5.58 (2.05)
4,511 (50.7%)
2,514 (28.3%)
1,871 (21.0%)

.253
.604
.809
.162

Significance reported as P values from Kruskall–Wallis comparing differences between groups.
Significance reported as P values from chi-square difference test.
Use of the MMAS-8 is protected by US copyright laws. Permission for use is required. A license agreement is available from Donald E. Morisky, 294 Lindura
Court, Las Vegas, NV 8,9138-4,632; dmorisky@gmail.com.
a

b

multivariable linear regression subset analyses were conducted. The results for rural versus urban cohorts based
on age groupings (aged 18-41, 42-64, and 65+) can be
found in Table 5. According to the regression analysis,
factors that are significantly associated with adherence
varied dependent on population density and age groupings. Comparing urban and rural while holding age group
constant revealed differences and similarities between rural and urban participants. For instance, adherence of rural and urban participants aged 65 and older were both
impacted by financial hardship (P = .004, P < .001, respectively) and perception of medication as a burden (P =
.010, P < .001, respectively); whereas only the adherence
for urban individuals over 65 years of age was impacted

by the use of drive-through pharmacies (P < .001), and
their overall health ranking (P < .001).

Discussion
Among all the different demographic factors, age had the
largest impact on adherence with those aged 18-29 reporting an average mean score of 4.85, while those aged
65 and over reported an average adherence score of 6.69,
with a higher score equating to better adherence. Additionally, increased income, increased education level,
male sex, and white race/ethnicity are all associated with
increased adherence for all participants in this study.
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Table 3 Adherence Scores among Different Demographic Groups Based on Rural, Suburban, or Urban Dwelling
Variables
Age Group
18-29
30-41
42-53
54-65
Over 65
Income
Income at or below $40,000
Income between $41,000 and $100,000
Income over $100,000
Education
High school degree or less
Some college to bachelor’s degree
Advanced degree
Sex
Male
Female
Ethnicity
White
Other

Rural
Suburban
Urban
Overall
Mean MMAS-8 Score (SD) Mean MMAS-8 Score (SD) Mean MMAS-8 Score (SD) Mean MMAS-8 Score (SD)
4.86 (2.07)
4.98 (2.21)
5.53 (1.99)
5.97 (1.87)
6.59 (1.54)

4.82 (2.12)
5.06 (2.09)
5.48 (1.98)
6.04 (1.78)
6.70 (1.50)

4.85 (2.07)
5.02 (2.12)
5.50 (2.04)
6.04 (1.81)
6.70 (1.50)

4.85 (2.09)
5.03 (2.12)
5.50 (2.01)
6.03 (1.81)
6.69 (1.50)

5.47 (2.10)
5.86 (1.96)
5.79 (1.88)

5.46 (2.07)
5.75 (1.98)
6.01 (1.85)

5.43 (2.08)
5.61 (2.04)
5.94 (1.92)

5.45 (2.08)
5.68 (2.02)
5.95 (1.90)

5.65 (2.05)
5.61 (2.04)
5.84 (1.99)

5.62 (2.05)
5.61 (2.00)
5.87 (2.00)

5.59 (2.05)
5.54 (2.04)
5.79 (2.08)

5.61 (2.05)
5.57 (2.03)
5.82 (2.05)

5.85 (1.93)
5.58 (2.07)

5.90 (1.94)
5.54 (2.04)

5.69 (2.06)
5.54 (2.04)

5.77 (2.02)
5.55 (2.04)

5.71 (2.01)
4.86 (2.23)

5.72 (1.99)
5.03 (2.14)

5.72 (2.01)
5.06 (2.13)

5.72 (2.00)
5.04 (2.14)

Initial interpretation of the data suggests that medication use and adherence is the same between rural,
suburban, and urban individuals. This is, however,
complicated by the fact that participant demographics
and general characteristics are different between each of
these groups. Previous research has established positive
relationships with age and female sex with increased
adherence to prescription medications. With the rural
group of participants being significantly older and having
a larger proportion of females than suburban and urban
participants, one would assume that the rural group
would have increased adherence rates.29,30 This is, however, counterbalanced by the fact the rural participants
reported lower income levels and an increased distance
to the nearest pharmacy, which are associated with
lower levels of medication adherence.
Based on separate regression analyses for rural and urban participants, the demographic and belief factors impacting adherence between rural and urban participants
vary (Tables 4 and 5). Adherence for rural participants
over the age of 65 was negatively influenced by financial
hardship of medications, whereas adherence for these
individuals was positively impacted by perceptions of
medication burden. Alternatively, adherence for urban
participants over the age of 65 was negatively impacted
by financial hardship, use of drive-through pharmacies,
and overall health ratings, but adherence was positively
affected by perceptions of medication burden.
Additionally, differences between factors that impact
adherence among different age groups of rural partici-

pants were shown. For instance, adherence for individuals aged 18-41 and 42-65 was impacted by overall health
score and use of drive-through pharmacies, while these
2 variables were not related to adherence of rural participants older than 65. The differential relationship between self-rated health status and adherence based on
age of rural participants may suggest that younger rural
participants with worse perceived health place increased
importance on adhering to their medication.
Financial hardship was shown to negatively impact
adherence across all age groups, regardless of being
identified as urban or rural dwellers. Although this factor
impacts medication for participants from all population
densities, it was hypothesized that this would be of
greater importance for rural participants, considering the
higher levels of poverty and lower median household incomes reported in rural areas compared to urban areas.31
This was, however, not supported by the results of this
study, which suggested financial hardship was equally
impactful for urban and rural dwellers. It is important
to note that the negative correlation between financial
hardship and adherence should be interpreted as higher
levels of agreement that medications cause financial
hardship is associated with lower MMAS-8 scores, which
equates to worse adherence. Similarly, the use of a
drive-through at the pharmacy was associated with
worse adherence, hence, the negative beta coefficient
reported in Table 4. However, this study is not able to
determine if these relationships are causative in nature.
Additional research is needed to evaluate this further.
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Table 4 Linear Regression of MMAS-8 Scores in Total Participant Population and Separated by Urban and Rural Population Densities
All Participants

(Intercept)
Education levela
Household incomea
Financial hardshipb
Age
Overall health
Distance
Mail order pharmacy usagec
Drive-through usagec
Burden
Life-saving
Overprescribed
Harm
Number of prescription medications
Observations
R2 /adj. R2

All Rural Participants

All Urban Participants

B∗

P

B∗

P

B∗

P

4.17
−0.07
0.06
−0.16
0.04
−0.43
0.00
−0.08
−0.30
0.18
0.04
0.05
0.10
−0.02

<.001
0.004
0.011
<.001
<.001
<.001
0.106
0.019
<.001
<.001
<.001
<.001
<.001
0.002

4.17
−0.09
0.06
−0.16
0.04
−0.41
0.00
−0.05
−0.35
0.21
0.06
0.07
0.04
−0.04

<.001
0.269
0.457
<.001
<.001
<.001
0.062
0.664
<.001
<.001
0.026
0.064
0.298
0.016

4.27
−0.05
0.06
−0.16
0.04
−0.45
−0.01
−0.14
−0.32
0.18
0.05
0.05
0.09
−0.02

<.001
0.128
0.052
<.001
<.001
<.001
<.001
0.002
<.001
<.001
<.001
<.001
<.001
0.029

15,933
.224/.223

1,735
.215/.209

8,896
.232/.231

∗Beta-coefficients reporting negative values indicate a negative association with adherence.
a
Education level and household income were input using categorical values, with lowest education level and lowest household income category serving
as the reference level.
b
Financial hardship was input as a continuous variable, with higher values relating to increased level of agreement of financial hardship caused by
medications.
c
Factors reported categorically with no serving as the reference level.
Table 5 Subset Multilinear Regression Analysis for Rural and Urban Participants Based on Age Groups
Rural 18-41
B
(Intercept)
Education level
Household income
Financial hardship
Overall health
Distance
Mail order pharmacy usage
Drive−through usage
Burden
Life-saving
Overprescribed
Harm
Number of prescription medications
Observations
R2 /adj. R2

P

5.26 <.001
0.04
.787
0.25
.098
−0.18 <.001
−0.61 <.001
0.01
.081
−0.25
.317
−0.42
.014
0.25 <.001
0.09
.060
0.08
.190
−0.03
.646
−0.01
.819
602
.151/.134

Urban 18-41
B

P

5.58 <.001
−0.01
.883
0.13
.013
−0.19 <.001
−0.52 <.001
−0.01
.002
−0.45 <.001
−0.34 <.001
0.16 <.001
0.07 <.001
0.05
.074
0.09 <.001
−0.03
.030
3,944
.147/.144

Limitations
This study had a number of limitations that the authors
wish to describe. First, data collection was conducted
electronically, which requires individuals to have internet and computer access to enroll in the study. This may

Rural 42-65
B

P

6.43 <.001
−0.30
.009
0.01
.950
−0.18 <.001
−0.36 <.001
0.01
.006
−0.08
.622
−0.39
.010
0.22 <.001
0.06
.161
0.07
.205
0.05
.375
−0.05
.037
782
.152/.139

Urban 42-65
B

P

5.93 <.001
−0.10
.090
0.07
.143
−0.15 <.001
−0.43 <.001
−0.01
.031
0.19
.014
−0.30 <.001
0.23 <.001
0.03
.172
0.05
.056
0.08
.005
0.01
.650
3,232
.134/.130

Rural 65+

Urban 65+

B

B

P

6.29 <.001
0.26
.050
−0.20
.161
−0.15
.004
−0.15
.272
−0.01
.074
0.13
.423
−0.24
.276
0.16
.010
0.07
.245
−0.08
.295
0.14
.059
−0.06
.057
351
.139/.109

P

6.53 <.001
0.03
.552
−0.02
.755
−0.12 <.001
−0.24 <.001
−0.01
.169
−0.08
.240
−0.35 <.001
0.17 <.001
0.05
.057
0.06
.051
0.04
.216
−0.03
.032
1,720
.138/.132

have been a limiting factor for both older populations
and those living in more rural areas. Second, the use
of a self-reported adherence scale, such as the MMAS8, does limit the researchers’ ability to verify the accuracy of the levels of adherence reported. The MMAS-8
has been widely used and validated, but self-reporting
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of adherence without incorporation of additional metrics
has potential limitations. Additionally, the data collected
only allowed researchers to report correlations between
individual factors and adherence. The nature of the data
collected does not allow researchers to determine if each
factor is causative in nature, which would require additional data collection. Last, it is important to note that
each subgroup did not contain the same number of responses.

Medication Adherence in Rural, Urban, and Suburban

6.

7.

8.

Conclusion
The percentage of participants falling into the low adherence category, approximately 50%, is similar between rural, urban, and suburban dwellers. This finding is similar
to previous research in medication adherence and is generally concerning. When comparing factors impacting adherence between rural and urban individuals and those
of different age clusters, distinct overall factors influencing adherence were identified for each group. However,
many adherence interventions to date target a single variable identified as a potential factor that impacts adherence. Based on the results of this study, adherence interventions should be further individualized, particularly
when considering population density and age.
Development of screening tools and targeted adherence approaches may increase the success of such adherence interventions. One factor that should be evaluated
among all participants is the impact of financial hardship
on medication use, as all participant groups had negative
associations between financial hardship and adherence.
Additionally, the use of the drive-through at local pharmacies should be further reviewed, as the reported use of
such services was negatively associated with adherence
across all participant groups.

9.

10.

11.
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